Hypertrophic Cardiomyopathy

P. Čapek; J. Škvor

doi:10.1055/s-0038-1634062

Methods of Information in Medicine, Inhaltsverzeichnis

Methods Inf Med 2006; 45(02): 169-172
DOI: 10.1055/s-0038-1634062

Original Article

Schattauer GmbH

Hypertrophic Cardiomyopathy

Molecular Genetic Analysis of Exons 9 and 11 of the TNNT2 Gene in Czech Patients

P. Čapek

¹EuroMISE Center, Prague, Czech Republic

²Department of Anthropology and Human Genetics, Faculty of Science, Charles University, Prague, Czech Republic

,

J. Škvor

¹EuroMISE Center, Prague, Czech Republic

²Department of Anthropology and Human Genetics, Faculty of Science, Charles University, Prague, Czech Republic

› Institutsangaben

Abstract

Summary

Objectives: Our research is a pilot study that specializes in the molecular genetic investigation of the TNNT2 gene in Czech patients with HCM/FHC disease. This study was initiated with exons 9 and 11 of TNNT2 because of their crucial role in the binding ability of cardiac troponin T to α-tropomyosin, and continued with analyses in other regions of the gene.

Methods: Hundred and eighty-one Czech probands with HCM/FHC were enrolled in this study. The study group consisted of 24 families with FHC and probands without FHC history but with HCM diagnosis. The clinical diagnosis was based on echocardiography. DNA was isolated from peripheral blood lymphocytes and subsequently analyzed by the polymerase chain reaction (PCR), followed by DNA sequencing analyses, which were cross-sequenced.

Results: The ΔGlu160 mutation was observed in a sequence of the TNNT2 gene in a patient with the severe form of hypertrophic cardiomyopathy. No sequence alteration was found in exons 9 and 11 of the TNNT2 gene found in the rest of the DNA samples.

Conclusion: The ΔGlu160 mutation was observed in patients with severe forms of hypertrophic cardiomyopathy. This region is responsible for binding troponin T to α-tropomyosin. This mutation may lead to functional and structural effects on the troponin T protein. Mutations in this region are reported relatively rarely and therefore it was unique to observe the ΔGlu160 mutation in our study.

Keywords

Cardiomyopathy - hypertrophic - familial - TNNT2 gene - mutation

Volltext

Referenzen

References
1 Palm T, Grabovski S, Hitchcock-DeGregori SE, Greenfield NJ. Disease-Causing Mutations in Cardiac Troponin T: Identification of a Critical Tropomyosin-Binding Region. Biophys J 2001; 81: 2827-37.
2 Anan R, Shono H, Kisanuki A, Arima S, Nakao S, Tanaka H. Patients with Familial Hypertrophic Cardiomyopathy Caused by a Phe110Ile Missense Mutation in the Cardiac Troponin T Gene Have Variable Cardiac Morphologies and a Favorable Prognosis. Circulation 1998; 98: 391-7.
3 Lin T-L. Ichihara S, Yamada Y, Nagasaka T, Ishihara H, Nakashima N, Yokota M. Phenotypic Variation of Familial Hypertrophic Cardiomyopathy Caused by the Phe110 → Ile Mutation in Cardiac Troponin T. Cardiology 2000; 93: 155-62.
4 Burhop J, Rosol M, Craigh R, Tabacman LS, Lehman W. Effects of a Cardiomyopathy-causing Troponin T Mutation on Thin Filament Function and Structure. J Biol Chem 2001; 276: 20788-94.
5 Keller DI, Carrier L, Schwartz K. Genetics of Familial Cardiomyopathies and arrhythmias. Swiss Med Wkly 2002; 132: 401-7.
6 Perry SV. Troponin T: Genetics, Properties and Function. J Muscle Res Cell Motility 1998; 19: 575-602.
7 Sehnert AJ, Huq A, Weinstein BM, Walker C, Fishman M, Stainier DY. Cardiac Troponin T is Essential in Sarcomere Assembly and Cardiac Contractility. Nat Genet 2002; 31: 106-10.
8 Townsend PJ, Farza H, MacGeoch C, Spurr NK, Wade R, Gahlmann R, Yacoub MH, Barton PJ. Human Cardiac Troponin T: Identification of Fetal Isoforms and Assignment of the TNNT2 Locus to Chromosome 1q. Genomics 1994; 21: 311-6.
9 Anderson PA, Greig A, Mark TM, Malouf NN, Oakeley AE, Ungerleider RM, Allen PD, Kay BK. Molecular Basis of Human Cardiac Troponin T Isoforms Expressed in the developing, adult, and failing heart. Circ Res 1995; 76: 681-6.
10 Mesnard L, Logeart D, Taviaux S, Diriong S, Mercadier JJ, Samson F. Human Cardiac Troponin T: Cloning and Expression of New Isoforms in the Normal and Failing Heart. Circ Res 1995; 76: 687-92.
11 Thierfelder L. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994; 77: 701-12.
12 Fujino N, Shimizu M, Ino H, Yamaguchi M, Yasuda T, Nagata M, Konno T, Mabuchi H. A Novel Mutation Lys273Glu in the Cardiac Troponin T Gene Shows High Degree of Penetrance and Transition from Hypertrohic to Dilated Cardiomyopathy. Am Jornal Cardiol 2002; 89: 29-33.
13 Harada K, Takahashi-Yanaga F, Minakami R, Morimoto S, Ohtsuki I. Functional Consequences of the Deletion Mutation Δ160 in Human Cardiac Troponin T. J Biochem 2000; 127: 263-8.
14 The Human Gene Mutation Database, Institute of Medical Genetics in Cardiff. http://archive.uwcm. ac.uk/uwcm/mg/hgmd0.html
15 Takahashi-Yanaga F, Ohtsuki I, Morimoto S. Effects of Troponin T Mutations in Familial Hypertrophic Cardiomyopathy on Regulatory Functions of Other Troponin Subunits. J Biochem 2001; 130: 127-31.
16 Sweeney HL, Feng HS, Yang Z, Watkins H. Functional Analyses of Troponin T Mutation that Cause Hypertrophic Cardiomyopathy: Insights into Disease Pathogenesis and Troponin Function. Proc Natl Acad Sci USA 1998; 95: 14406-10.
17 Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O’Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE. Mutations in the Genes for cardiac troponin T and α-Tropomyosin in Hypertrophic Cardiomyopathy. New Engl J Med1995 332: 1058-65.
18 Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet J-P. Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M. Hypertrophic Cardiomyopathy. Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy. Circulation 2003; 107: 2227-32.